FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants

The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.

Copyright 2021 NPR

  • Facebook
  • Twitter
  • LinkedIn
  • Email
Sydney Lupkin is the pharmaceuticals correspondent for NPR.